Zhou, Nina
Liu, Chang
Guo, Xiaoyi
Xu, Yuping
Gong, Jifang
Qi, Changsong
Zhang, Xiaotian
Yang, Min
Zhu, Hua
Shen, Lin
Yang, Zhi http://orcid.org/0000-0003-2084-5193
Funding for this research was provided by:
the National Key Research and Development Program of China (2017YFC1308900)
National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2017ZX09304021)
National Natural Science Foundation (31671035, 81472749)
Beijing Natural Science Foundation, Jing-Jin-Ji special projects for basic research cooperation (H2018206600)
Beijing Excellent Talents Funding (2017000021223ZK33)
Beijing Municipal Administration of Hospitals-Yangfan Project (ZYLX201816)
Jiangsu Provincial Natural Science Foundation (BK20170204)
Jiangsu Health International Exchange Program (JSH-2018-015)
Jiangsu talent projects (LGY2017088)
Jiangsu Provincial Commission of Health and Family Planning Foundation (H2017031)
Wuxi Commission of Health and Family Planning Foundation (Q201729)
Jiangsu Program for Innovation Research Team (CXTDA2017024)
Article History
Received: 20 March 2020
Accepted: 1 June 2020
First Online: 20 June 2020
Compliance with ethical standards
:
: The authors declare that they have no potential conflict of interests.
: All procedures in this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later versions. Informed consent was, or its equivalent, was obtained from all patients included in the study. The clinical study was approved by the Ethics Committee of the Beijing Cancer Hospital (ethical approval no. 2018KT61).
: Informed consent was obtained from the 34 individual participants included in this study.